Page 2 - Biotechnology Vector News Today

NeoCoV is the closest ?relative? of the variant that caused deadly outbreaks in 2015 Chinese scientists have discovered that a NeoCoV stra

NeoCoV is the closest ?relative? of the variant that caused deadly outbreaks in 2015 Chinese scientists have discovered that a NeoCoV stra

The Russian State Research Centre for Virology and Biotechnology Vector has released the first photograph of a new variant of coronavirus...

Mushrooms, long valued for their medicinal properties, are being explored as tools to boost immunity and fight viruses, ...

This variant has been under observation since November 2020 and has been detected in 43 countries

У Росії один пацієнт із коронавірусом заразив інфекцією одразу 1,5 тисячі осіб. Це максимальний випадок суперпоширення, який зафіксували в країні, пише ТАСС з посиланням на главу філії Державного наук

The estimates were based on research involving the first group of volunteers who had received the vaccine nine months back

Venezuela launches clinical trials of Russia’s EpiVacCorona jab Acting Vice President of Venezuela Delcy Rodriguez expressed confidence that this is "a good vaccine" and hoped that Venezuela would be able to use it to inoculate its population Russian Ambassador to Venezuela Sergei Melik-Bagdasarov© Andrei Ulinkin/TASS RIO DE JANEIRO, May 5. /TASS/. Venezuela has launched clinical trials of Russia’s EpiVacCorona vaccine on Tuesday. Russian Ambassador to Venezuela Sergei Melik-Bagdasaro...

Over 90% inoculated with EpiVacCorona jab developed COVID-19 antibodies, says researcher EpiVacCorona, developed by the Russian sanitary watchdog’s State Research Center of Virology and Biotechnology Vector, is Russia’s second coronavirus vaccine © Maxim Slutsky/TASS MOSCOW, May 5. /TASS/. More than 90% of people inoculated with the EpiVacCorona vaccine developed antibodies to COVID-19, Chief of the Russian State Research Center of Virology and Biotechnology Vector’s zoonotic inf...

Center Vector to check if EpiVacCorona is effective against Indian virus strain Earlier, the head of Russia’s consumer rights watchdog Anna Popova said that Russia had requested a sample of the Indian strain of the coronavirus and it would be obtained for examination soon MOSCOW, May 3. /TASS/. Russia’s research center Vector is going to test the effectiveness of its vaccine EpiVacCorona, against the Indian strain of the coronavirus as soon as it becomes available, the center’s deputy ...